Showing results (791-800 of 6,096) with videos related to
Sort By:
Pageof 610
International Journal of Antimicrobial Agents|July 22, 2018
A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltrationFekade B Sime, Janine Stuart, Jenie Butler, et al.International Journal of Antimicrobial Agents|July 25, 2018
Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studiesKunchok Dorjee, Tsering Choden, Sanjiv M Baxi, et al.International Journal of Antimicrobial Agents|May 30, 2017
Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasisHollie Burrell-Saward, Andrew J Harris, Raul de LaFlor, et al.International Journal of Antimicrobial Agents|June 6, 2017
Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureusVasileios Soranoglou, Ilias Galanopoulos, Evangelos J Giamarellos-Bourboulis, et al.International Journal of Antimicrobial Agents|June 6, 2017
Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniaeMiyuki Morozumi, Takafumi Okada, Takeshi Tajima, et al.International Journal of Antimicrobial Agents|September 11, 2016
Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case seriesPaulo Mendes Peçanha, Stella de Souza, Aloísio Falqueto, et al.International Journal of Antimicrobial Agents|March 16, 2010
Interaction of the antimicrobial peptide melimine with bacterial membranesR Rasul, N Cole, D Balasubramanian, et al.International Journal of Antimicrobial Agents|June 10, 2017
Role of second-line injectable antituberculosis drugs in the treatment of MDR/XDR tuberculosisFanny Quenard, Pierre Edouard Fournier, Michel Drancourt, et al.International Journal of Antimicrobial Agents|April 26, 2017
A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumanniiElias Dahdouh, Rosa Gómez-Gil, Sonia Sanz, et al.International Journal of Antimicrobial Agents|May 1, 2017
Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, ChinaWenzi Bi, Bin Li, Jiangning Song, et al.Pageof 610